764 related articles for article (PubMed ID: 28555425)
1. Ethical considerations of neuro-oncology trial design in the era of precision medicine.
Gupta S; Smith TR; Broekman ML
J Neurooncol; 2017 Aug; 134(1):1-7. PubMed ID: 28555425
[TBL] [Abstract][Full Text] [Related]
2. Innovation in oncology clinical trial design.
Verweij J; Hendriks HR; Zwierzina H;
Cancer Treat Rev; 2019 Mar; 74():15-20. PubMed ID: 30665053
[TBL] [Abstract][Full Text] [Related]
3. Precision medicine ethics: selected issues and developments in next-generation sequencing, clinical oncology, and ethics.
Fiore RN; Goodman KW
Curr Opin Oncol; 2016 Jan; 28(1):83-7. PubMed ID: 26569425
[TBL] [Abstract][Full Text] [Related]
4. New clinical trial designs in the era of precision medicine: An overview of definitions, strengths, weaknesses, and current use in oncology.
Janiaud P; Serghiou S; Ioannidis JPA
Cancer Treat Rev; 2019 Feb; 73():20-30. PubMed ID: 30572165
[TBL] [Abstract][Full Text] [Related]
5. Integrating genomics into clinical oncology: ethical and social challenges from proponents of personalized medicine.
McGowan ML; Settersten RA; Juengst ET; Fishman JR
Urol Oncol; 2014 Feb; 32(2):187-92. PubMed ID: 24445286
[TBL] [Abstract][Full Text] [Related]
6. Personalised medicine in paediatric oncology: Ethical practice outside the clinical trial framework?
Hansford JR
J Paediatr Child Health; 2019 Jan; 55(1):10-12. PubMed ID: 30499210
[TBL] [Abstract][Full Text] [Related]
7. Umbrella and basket trials in oncology: ethical challenges.
Strzebonska K; Waligora M
BMC Med Ethics; 2019 Aug; 20(1):58. PubMed ID: 31443704
[TBL] [Abstract][Full Text] [Related]
8. Ethics of Pharma Clinical Trials in the Era of Precision Oncology.
Turner JH
Cancer Biother Radiopharm; 2021 Feb; 36(1):1-9. PubMed ID: 32935997
[TBL] [Abstract][Full Text] [Related]
9. Balancing the Economics and Ethics of Personalised Oncology.
Flaum N; Hall P; McCabe C
Trends Cancer; 2018 Sep; 4(9):608-615. PubMed ID: 30149879
[TBL] [Abstract][Full Text] [Related]
10. Precision medicine in pediatric oncology.
Forrest SJ; Geoerger B; Janeway KA
Curr Opin Pediatr; 2018 Feb; 30(1):17-24. PubMed ID: 29189430
[TBL] [Abstract][Full Text] [Related]
11. Future Approaches to Precision Oncology-Based Clinical Trials.
Mittra A; Moscow JA
Cancer J; 2019; 25(4):300-304. PubMed ID: 31335395
[TBL] [Abstract][Full Text] [Related]
12. Current-day precision oncology: from cancer prevention, screening, drug development, and treatment - have we fallen short of the promise?
Morgan G; Aftimos P; Awada A
Curr Opin Oncol; 2016 Sep; 28(5):441-6. PubMed ID: 27428363
[TBL] [Abstract][Full Text] [Related]
13. Definitions and statistical properties of master protocols for personalized medicine in oncology.
Renfro LA; Mandrekar SJ
J Biopharm Stat; 2018; 28(2):217-228. PubMed ID: 28877008
[TBL] [Abstract][Full Text] [Related]
14. Implementing Precision Medicine Programs and Clinical Trials in the Community-Based Oncology Practice: Barriers and Best Practices.
Ersek JL; Black LJ; Thompson MA; Kim ES
Am Soc Clin Oncol Educ Book; 2018 May; 38():188-196. PubMed ID: 30231363
[TBL] [Abstract][Full Text] [Related]
15. Development of the CNS TAP tool for the selection of precision medicine therapies in neuro-oncology.
Linzey JR; Marini BL; Pasternak A; Smith C; Miklja Z; Zhao L; Kumar-Sinha C; Paul A; Harris N; Robertson PL; Hoffman LM; Chinnaiyan A; Mody R; Koschmann C
J Neurooncol; 2018 Mar; 137(1):155-169. PubMed ID: 29235051
[TBL] [Abstract][Full Text] [Related]
16. The changing face of clinical trials in the personalized medicine and immuno-oncology era: report from the international congress on clinical trials in Oncology & Hemato-Oncology (ICTO 2017).
Golan T; Milella M; Ackerstein A; Berger R
J Exp Clin Cancer Res; 2017 Dec; 36(1):192. PubMed ID: 29282151
[TBL] [Abstract][Full Text] [Related]
17. Next generation neuro-oncology.
Weller M
Eur J Cancer; 2018 Jun; 96():1-5. PubMed ID: 29656021
[TBL] [Abstract][Full Text] [Related]
18. Perspective on Precision Medicine in Oncology.
Johnson TM
Pharmacotherapy; 2017 Sep; 37(9):988-989. PubMed ID: 28632968
[TBL] [Abstract][Full Text] [Related]
19. Budget impact and cost-effectiveness: can we afford precision medicine in oncology?
Doble B
Scand J Clin Lab Invest Suppl; 2016; 245():S6-S11. PubMed ID: 27426412
[TBL] [Abstract][Full Text] [Related]
20. An overview of precision oncology basket and umbrella trials for clinicians.
Park JJH; Hsu G; Siden EG; Thorlund K; Mills EJ
CA Cancer J Clin; 2020 Mar; 70(2):125-137. PubMed ID: 32031692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
